Početna › Ulcerativni kolitis › Texas
Kliničke studije za Ulcerativni kolitis u državi Texas
33 studija za Ulcerativni kolitis traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
- Houston17 studija
- San Antonio16 studija
- Tyler14 studija
- Lewisville10 studija
- Lubbock9 studija
- Garland8 studija
- Round Rock8 studija
- Dallas8 studija
- Fort Worth7 studija
- League City6 studija
- The Woodlands5 studija
- Arlington4 studija
Službeni tekst studije (engleski)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- i još 3
U tijeku regrutacijaFaza 3
Sve dobne skupine · Oba spola · Ažurirano 2. lis 2026. · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- i još 9
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- i još 7
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Texas - Southwestern Medical Center /ID# 271835, Dallas
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
- Southern Star Research Institute, San Antonio
U tijeku regrutacijaFaza 2
Od 16 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- i još 8
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- i još 2
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- i još 4
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Victorium Clinical Research, Houston
- i još 3
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
U tijeku regrutacijaFaza 3
Od 3 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0103, Fort Worth
- Texas Children's Hospital, Houston
U tijeku regrutacijaFaza 2/3
Od 2 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- i još 2
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Texas Digestive Disease Consultants - Cedar Park, Cedar Park
- GI Alliance - Dallas - Gaston Avenue, Dallas
- GI Alliance - Fort Worth, Fort Worth
- i još 5
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Fort Worth, Fort Worth
- GI Alliance - Garland, Garland
- Integrity Advanced Therapeutics, Houston
- i još 4
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- GI Alliance - Digestive Health Associates of Texas, Dallas
- The University of Texas Health Science Center at Houston, Houston
- GI Alliance - Mansfield, Mansfield
- i još 4
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
- Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
- i još 1
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT07577856A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT04372108A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Texas Digestive Disease Consultants, Cedar Park
- Baylor College of Medicine, Houston
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 21. kol 2026. · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research - Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
- Valley Institute of Research - Site Number: 8400004, Harlingen
- i još 7
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
U tijeku regrutacija
Od 18 do 85 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06571669An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
- Brooke Army Medical center, San Antonio
- i još 2
U tijeku regrutacijaOpažajna studija
Od 18 do 64 godina · Oba spola · Ažurirano 9. srp 2026. · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- ACT-Midwest G1, Abilene
U tijeku regrutacijaFaza 2
Od 12 do 17 godina · Oba spola · Ažurirano 8. srp 2026. · NCT05287126A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06764615Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 20. svi 2026. · NCT04751396A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
U tijeku regrutacijaFaza 3
Od 2 godina i više · Oba spola · Ažurirano 7. svi 2026. · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- i još 5
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT07113522Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
U tijeku regrutacijaOpažajna studija
Od 18 do 100 godina · Oba spola · Ažurirano 18. svi 2021. · NCT04617184Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.